Notably, STING expression in MoMFs is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) and HBV infection (83, 84). Here, STING1 is linked to metabolic dysfunction-associated steatotic liver disease.